A team flagged data-integrity issues in 130 studies by a biomedical researcher, Ahmed Abbas, and colleagues, published between 2014-2023. Concerns include odd statistics, unfeasible results, and duplicated text. Eleven studies have been retracted, impacting clinical practice. Women’s health specialists are developing strategies to prevent questionable data publication.